The result was announced after market hours on Friday, 26 May 2017.

Meanwhile, the S&P BSE Sensex was down 8.19 points, or 0.03% at 31,020.02.The S&P BSE Mid-Cap Index was down 158.88 points, or 1.09% at 14,361.02.

On the BSE, 9,026 shares were traded on the counter so far as against the average daily volumes of 4.63 lakh shares in the past on quarter. The stock had hit a high of Rs 184.40 and a low of Rs 178 so far during the day.

The stock had hit a 52-week high of Rs 240 on 10 November 2016 and a 52-week low of Rs 165.50 on 24 June 2016. The stock had underperformed the market over the past one month till 26 May 2017, declining 9.91% compared with the Sensex's 2.97% rise. The scrip had also underperformed the market over the past one quarter declining 16.95% as against the Sensex's 7.39% rise.

The mid-cap company has equity capital of Rs 17.78 crore. Face value per share is Rs 1.

FDC's board of directors recommended a dividend of Rs 2.25 per equity share for the year ended March 2017.

FDC is a pharmaceutical company. The company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).